PC
AMED

Polar Capital’s Amedisys AMED Stock Holding History

Polar Capital’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$448K Sell
1,893
-205,267
-99% -$46.7M ﹤0.01% 280
2020
Q2 		$41.1M Buy
207,160
+204,567
+7,889% +$38.2M 0.36% 85
2020
Q1 		$476K Buy
+2,593
New +$461K 0.01% 270
2017
Q1 		– Sell
-386,696
Closed -$16.5M – 254
2016
Q4 		$16.5M Buy
386,696
+146,096
+61% +$6.21M 0.26% 124
2016
Q3 		$11.4M Buy
+240,600
New +$12M 0.2% 137

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Polar Capital's AMED Position: Q3 2020 in Review

Polar Capital reduced its Amedisys (AMED) stake by 99% in Q3 2020, selling an estimated $46.7M and leaving 1,893 shares worth $448K. The position accounts for ﹤0.01% of the portfolio, ranked #280.

Polar Capital first reported a position in AMED in Q3 2016 and has held it in 5 quarters since. The position peaked at $41.1M in Q2 2020. 397 funds tracked by Wall St. Rank hold AMED as of Q3 2020.

  • Polar Capital held 1,893 shares of Amedisys worth $448K as of Q3 2020.
  • Polar Capital sold 205,267 Amedisys shares in Q3 2020, an estimated $46.7M.
  • Amedisys made up ﹤0.01% of Polar Capital's portfolio in Q3 2020, its #280 holding.
  • Polar Capital first reported a position in Amedisys in Q3 2016 and has held it in 5 quarters since.
  • Polar Capital's Amedisys position peaked at $41.1M in Q2 2020.
  • 397 funds tracked by Wall St. Rank held Amedisys as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.